Sophiris Bio (SPHS) Reports Q4 Loss of $0.15

Sophiris Bio (NASDAQ: SPHS) reported Q4 EPS of ($0.15), versus ($0.31) reported last year.

For earnings history and earnings-related data on Sophiris Bio (SPHS) click here.

You May Also Be Interested In

• Concentrix Corporation (CNXC) Misses Q2 EPS by 1c; Guides lower than expectations
• Logitech dips as BofA downgrades stock on demand outlook concerns
• Novocure's Optune Pax wins CE Mark for pancreatic cancer